EPS 2.27 SO THAT is why it run to 3.84 on news, they run on milestones. start of phase 3, this bs offering gives me chance to buy. at lower prices. and in coming weeks, it goes again
still here, market has twice daily creams for acne, but this is the first once weekly application, hit 2.08 other day, the number ratio has a solid effectiveness rate here. doubled up at 1.57. with FDA event in coming weeks